In vitro evaluation of TLR4 agonist activity: formulation effects.

In vitro evaluation of TLR4 agonist activity: formulation effects.

Item
http://www.wikidata.org/entity/Q30561113
Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica.A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes.A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 ActivationOptimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activityCryogenic transmission electron microscopy of recombinant tuberculosis vaccine antigen with anionic liposomes reveals formation of flattened liposomes.Physicochemical and functional characterization of vaccine antigens and adjuvants.Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach.Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γ.Analysis of the Innate Response to Adjuvants: Characterization of the Draining Lymph Node by Fluorescence-Activated Cell Sorting.Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for Entamoeba histolytica.A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika
P2860

In vitro evaluation of TLR4 agonist activity: formulation effects.

Item
http://www.wikidata.org/entity/Q30561113
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
In vitro evaluation of TLR4 agonist activity: formulation effects.
@ast
In vitro evaluation of TLR4 agonist activity: formulation effects.
@en
type
label
In vitro evaluation of TLR4 agonist activity: formulation effects.
@ast
In vitro evaluation of TLR4 agonist activity: formulation effects.
@en
prefLabel
In vitro evaluation of TLR4 agonist activity: formulation effects.
@ast
In vitro evaluation of TLR4 agonist activity: formulation effects.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
In vitro evaluation of TLR4 agonist activity: formulation effects.
@en
P2093
P2860
P304
P31
P356
10.1016/J.COLSURFB.2013.09.006
P478
P50
P577
P698
P921
P932